Belite Total Assets from 2010 to 2025
| BLTE Stock | USD 67.28 0.45 0.66% |
Total Assets | First Reported 2020-03-31 | Previous Quarter 115.8 M | Current Value 152.1 M | Quarterly Volatility 47.1 M |
Check Belite Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Belite Bio's main balance sheet or income statement drivers, such as Tax Provision of 5.5 K, Net Interest Income of 3.9 M or Interest Income of 3.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 12.71 or Days Sales Outstanding of 0.0. Belite financial statements analysis is a perfect complement when working with Belite Bio Valuation or Volatility modules.
Belite | Total Assets |
Latest Belite Bio's Total Assets Growth Pattern
Below is the plot of the Total Assets of Belite Bio ADR over the last few years. Total assets refers to the total amount of Belite Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Belite Bio ADR books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Belite Bio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Belite Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 152.13 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Belite Total Assets Regression Statistics
| Arithmetic Mean | 47,017,788 | |
| Geometric Mean | 35,421,757 | |
| Coefficient Of Variation | 97.98 | |
| Mean Deviation | 33,182,405 | |
| Median | 25,741,000 | |
| Standard Deviation | 46,066,802 | |
| Sample Variance | 2122.2T | |
| Range | 141.4M | |
| R-Value | 0.69 | |
| Mean Square Error | 1197.9T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 6,655,875 | |
| Total Sum of Squares | 31832.3T |
Belite Total Assets History
Other Fundumenentals of Belite Bio ADR
Belite Bio Total Assets component correlations
Click cells to compare fundamentals
About Belite Bio Financial Statements
Belite Bio stakeholders use historical fundamental indicators, such as Belite Bio's Total Assets, to determine how well the company is positioned to perform in the future. Although Belite Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Belite Bio's assets and liabilities are reflected in the revenues and expenses on Belite Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Belite Bio ADR. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 152.1 M | 159.7 M | |
| Intangibles To Total Assets | 0.03 | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Belite Bio Correlation against competitors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.